CBAT Q2 2025: 45% Residential Market Drop Forces Model Shift and Delays Recovery
CBAT’s Q2 revealed the full impact of a strategic pivot away from legacy small-format batteries, as residential energy storage sales plummeted and new model ramp delays suppressed growth. The company is now betting on larger-format cells and expansion projects to restore momentum, but execution risk remains high until new capacity comes online. Investors face a transition period where near-term headwinds overshadow longer-term ambitions.
Summary
- Legacy Market Exposure: Heavy reliance on aging small-format batteries left CBAT vulnerable as residential demand collapsed.
- Capacity Bottlenecks: Nanjing plant ran at full tilt, but expansion delays limited ability to capture surging demand for new models.
- Recovery Hinges on Execution: Full-year rebound depends on timely completion of new lines and successful customer ramp-up.
Performance Analysis
CBAT’s Q2 performance was defined by double-digit revenue contraction as the Dalian facility’s transition away from the mature model 26600 battery exposed the business to a sharp drop in residential energy storage sales. This segment, previously a major revenue pillar, saw a 44.8% year-over-year decline, fundamentally altering the company’s customer mix. The resulting shortfall was only partially offset by increased orders from the portable power supply sector and rapid growth in India’s two- and three-wheeler battery markets.
The Nanjing facility, focused on the newer model 32140 cell, operated at full capacity with phase two expansion delayed until Q4 due to supplier issues. This bottleneck prevented CBAT from capitalizing on robust demand, particularly from high-quality European and American customers. Meanwhile, the raw materials segment, HITRANS, delivered a bright spot with revenue up 59% and narrowing losses, reflecting improved market penetration and the benefit of lower raw material prices stimulating demand.
- Revenue Mix Shift: Portable power and Indian mobility customers grew in importance as residential storage demand cratered.
- Margin Pressure: Battery segment losses widened, while HITRANS reduced its losses through scale and cost discipline.
- Supply Constraints: Full utilization at Nanjing capped growth, with expansion delays directly impacting order fulfillment.
CBAT’s near-term financial profile is now defined by transition costs, capacity constraints, and a race to bring new, larger-format batteries to market before competitors erode pricing power further.
Executive Commentary
"This transition has led to a sharp decline in Dalian's net revenues and gross profit. ... Nanjing is operating at a full capacity and are able to accommodate further demand until phase two comes online. Since both the model 4135 production and Nanjing phase two expansion are expected to be ready in Q3 to Q4, we anticipate a strong recovery in our consolidated results by year-end."
Zhiguang Hu, Chief Executive Officer
"Net revenues for HITRANS reached approximately 19.43 million, up 59.36% from 12.19 million in the same period of 2024. Its net losses narrowed by 32.02% ... This improvement reflects Hytran's sustained efforts to expand its market presence."
Thierry Li, Chief Financial Officer & Company Secretary
Strategic Positioning
1. Transition to Larger-Format Cells
CBAT is deliberately phasing out legacy small-format batteries like the 26600, which have lost competitiveness as market demand shifts toward higher-capacity, lower-cost solutions. The new 40135 and 32140 models are designed to address this shift, targeting applications in portable power and electric mobility, especially in India and with global OEMs.
2. Capacity Expansion and Execution Risk
The Nanjing facility’s phase two expansion delay—caused by supplier equipment issues—has become a critical bottleneck. Until new lines are operational, CBAT cannot meet incremental demand, risking customer attrition and missed market opportunities. Dalian’s new 40135 line is also in the sample testing phase, with revenue contribution not expected until Q4.
3. Selective Capital Allocation and Tariff Response
CBAT’s response to US tariffs included a now-paused plan to relocate some production overseas. Management is taking a wait-and-see approach, monitoring trade negotiations before committing further capital. Long-term, US capacity remains a strategic goal, but near-term focus is on maximizing returns from existing projects and preserving capital for the critical 46-series R&D ramp.
4. HITRANS as a Diversification Lever
The raw materials unit, HITRANS, is showing resilience and potential as a partial offset to battery segment volatility. By capturing new customers and benefiting from lower input prices, HITRANS is positioned to contribute more meaningfully once battery segment volumes recover.
Key Considerations
CBAT’s Q2 underscores a business in the midst of high-stakes transformation, with near-term pain a trade-off for longer-term strategic repositioning. The company’s ability to execute on new product launches and capacity expansions will determine whether it can reclaim lost ground in 2026.
Key Considerations:
- Execution Timelines: Delays in Nanjing phase two and Dalian 40135 ramp are gating factors for any near-term recovery.
- Customer Diversification: Shift toward Indian and portable power customers reduces reliance on a single end market but introduces new competitive risks.
- Cost Structure Evolution: Larger-format cells are intended to restore margin, but require scale and capital investment to achieve cost targets.
- Tariff and Trade Uncertainty: Paused US expansion reflects prudent capital discipline, but exposes CBAT to ongoing geopolitical risk.
Risks
CBAT faces significant execution risk as it attempts to bring new capacity online amid a rapidly evolving competitive and regulatory landscape. Prolonged delays or technical issues could result in further market share loss, while pricing pressure from both prismatic and cylindrical cell competitors remains intense. The company’s dependence on equipment suppliers and capital markets for expansion funding adds another layer of uncertainty, especially as legacy revenue streams erode faster than new ones scale up.
Forward Outlook
For Q3 and Q4 2025, CBAT expects:
- Completion of Dalian 40135 and Nanjing phase two expansions, enabling higher order fulfillment.
- Continued growth in HITRANS raw materials revenue, supported by new customer wins and stabilizing input prices.
For full-year 2025, management did not provide explicit guidance but reiterated:
- Strong rebound in consolidated results is anticipated by year-end, contingent on successful ramp of new production lines.
Management highlighted several factors that will shape the outlook:
- Resolution of equipment delays as a gating factor for capacity expansion.
- Monitoring of US-China tariff negotiations before resuming overseas investment.
Takeaways
CBAT’s Q2 results mark a critical inflection point as the company’s pivot away from legacy products exposes near-term revenue and margin headwinds. The investment case now rests on the timely execution of new expansion projects and the successful commercialization of larger-format batteries, with HITRANS providing some downside buffer.
- Transition Risk Dominates: Legacy segment decline outpaced new product ramp, creating a near-term earnings trough.
- Recovery Depends on Project Delivery: Q4 will be pivotal as new capacity comes online and customer adoption is tested.
- Watch for Execution Signals: Investors should monitor progress on Nanjing and Dalian expansions, as well as customer traction for new cell formats.
Conclusion
CBAT’s Q2 underscores the challenges of business model transformation in a fast-moving battery market. While management’s strategy to shift toward larger, more cost-effective cells aligns with industry trends, the window for execution is narrow and fraught with operational risk. Investors should expect continued volatility until new capacity and product ramps are proven at scale.
Industry Read-Through
CBAT’s experience highlights the hazards of overreliance on legacy battery formats as the global energy storage and mobility markets accelerate their shift to larger, more efficient cell architectures. The company’s struggles with capacity expansion, supply chain reliability, and tariff-driven capital allocation are emblematic of broader industry pressures facing mid-tier battery manufacturers. For sector peers, the quarter underscores the imperative to manage product transitions and global supply chain complexity with agility, or risk margin compression and customer churn as demand migrates to next-generation formats.